These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 36931548)

  • 21. Client and provider experiences with self-administration of subcutaneous depot medroxyprogesterone acetate (DMPA-SC) in Malawi.
    Burke HM; Packer C; Buluzi M; Healy E; Ngwira B
    Contraception; 2018 Nov; 98(5):405-410. PubMed ID: 29706227
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of training in effective simulated self-injection of subcutaneous depot medroxyprogesterone acetate: observations from a usability study.
    Kaplan I; Ross D; Hilton F; Morgenstern D; Wolter K
    Contraception; 2016 Oct; 94(4):314-20. PubMed ID: 27241898
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The safety of subcutaneously administered depot medroxyprogesterone acetate (104mg/0.65mL): A systematic review.
    Dragoman MV; Gaffield ME
    Contraception; 2016 Sep; 94(3):202-15. PubMed ID: 26874275
    [TBL] [Abstract][Full Text] [Related]  

  • 24. "Men can take part": examining men's role in supporting self-injectable contraception in southern Malawi, a qualitative exploration.
    Ruderman LW; Packer C; Zingani A; Moses P; Burke HM
    Reprod Health; 2022 Aug; 19(1):174. PubMed ID: 35945601
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is contraceptive self-injection cost-effective compared to contraceptive injections from facility-based health workers? Evidence from Uganda.
    Di Giorgio L; Mvundura M; Tumusiime J; Morozoff C; Cover J; Drake JK
    Contraception; 2018 Nov; 98(5):396-404. PubMed ID: 30098940
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expanding Access to Injectable Contraception: Results From Pilot Introduction of Subcutaneous Depot Medroxyprogesterone Acetate (DMPA-SC) in 4 African Countries.
    Stout A; Wood S; Barigye G; Kaboré A; Siddo D; Ndione I
    Glob Health Sci Pract; 2018 Mar; 6(1):55-72. PubMed ID: 29602866
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Role of Subcutaneous Depot Medroxyprogesterone Acetate in Equitable Contraceptive Care: A Lesson From the Coronavirus Disease 2019 (COVID-19) Pandemic.
    Burlando AM; Flynn AN; Gutman S; McAllister A; Roe AH; Schreiber CA; Sonalkar S
    Obstet Gynecol; 2021 Oct; 138(4):574-577. PubMed ID: 34623069
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acceptability of the distribution of DMPA-SC by community health workers among acceptors in the rural province of Lualaba in the Democratic Republic of the Congo: a pilot study.
    Mwembo A; Emel R; Koba T; Sankoko JB; Ngay A; Gay R; Bertrand JT
    Contraception; 2018 Nov; 98(5):454-459. PubMed ID: 30118683
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Would you be interested in DMPA-SC? An implementation project in two urban primary care clinics.
    Miles C; Ennamuri D; Yeh J; Shih G
    Contraception; 2022 Aug; 112():116-119. PubMed ID: 35123982
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Subcutaneous DMPA vs. intramuscular DMPA: a 2-year randomized study of contraceptive efficacy and bone mineral density.
    Kaunitz AM; Darney PD; Ross D; Wolter KD; Speroff L
    Contraception; 2009 Jul; 80(1):7-17. PubMed ID: 19501210
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pilot study of home self-administration of subcutaneous depo-medroxyprogesterone acetate for contraception.
    Cameron ST; Glasier A; Johnstone A
    Contraception; 2012 May; 85(5):458-64. PubMed ID: 22079602
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence-Based Guidance for Self-Administration of Injectable Contraception.
    Marx M
    J Midwifery Womens Health; 2021 Jan; 66(1):108-112. PubMed ID: 33369137
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Introduction of Subcutaneous Depot Medroxyprogesterone Acetate (DMPA-SC) Injectable Contraception at Facility and Community Levels: Pilot Results From 4 Districts of Uganda.
    Odwe G; Gray K; Kyarimpa A; Obare F; Nagendi G
    Glob Health Sci Pract; 2018 Dec; 6(4):711-722. PubMed ID: 30429201
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Introducing the subcutaneous depot medroxyprogesterone acetate injectable contraceptive via social marketing: lessons learned from Nigeria's private sector.
    Liu J; Schatzkin E; Omoluabi E; Fajemisin M; Onuoha C; Erinfolami T; Ayodeji K; Ogunmola S; Shen J; Diamond-Smith N; Sieverding M
    Contraception; 2018 Nov; 98(5):438-448. PubMed ID: 30071196
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Continuation of injectable contraception when self-injected vs. administered by a facility-based health worker: a nonrandomized, prospective cohort study in Uganda.
    Cover J; Namagembe A; Tumusiime J; Nsangi D; Lim J; Nakiganda-Busiku D
    Contraception; 2018 Nov; 98(5):383-388. PubMed ID: 29654751
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adolescent and covert family planning users' experiences self-injecting contraception in Uganda and Malawi: implications for waste disposal of subcutaneous depot medroxyprogesterone acetate.
    Burke HM; Packer C; Wando L; Wandiembe SP; Muwereza N; Pradhan S; Zingani A; Ngwira B
    Reprod Health; 2020 Aug; 17(1):117. PubMed ID: 32746860
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Self-administration of subcutaneous depot medroxyprogesterone acetate for contraception: feasibility and acceptability.
    Prabhakaran S; Sweet A
    Contraception; 2012 May; 85(5):453-7. PubMed ID: 22079605
    [TBL] [Abstract][Full Text] [Related]  

  • 38. What Distinguishes Women Who Choose to Self-Inject? A Prospective Cohort Study of Subcutaneous Depot Medroxyprogesterone Acetate Users in Ghana.
    Nai D; Tobey E; Fuseini K; Kuma-Aboagye P; Jain A
    Glob Health Sci Pract; 2022 Feb; 10(1):. PubMed ID: 35294390
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Costs of administering injectable contraceptives through health workers and self-injection: evidence from Burkina Faso, Uganda, and Senegal.
    Di Giorgio L; Mvundura M; Tumusiime J; Namagembe A; Ba A; Belemsaga-Yugbare D; Morozoff C; Brouwer E; Ndour M; Drake JK
    Contraception; 2018 Nov; 98(5):389-395. PubMed ID: 29859148
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Young Women's Experiences With Subcutaneous Depot Medroxyprogesterone Acetate: A Secondary Analysis of a One-Year Randomized Trial in Malawi.
    Burke HM; Chen M; Packer C; Fuchs R; Ngwira B
    J Adolesc Health; 2020 Nov; 67(5):700-707. PubMed ID: 32389457
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.